Nuvation Bio, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US67080N1019
USD
5.76
0.2 (3.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Nuvation Bio, Inc.
MaxCyte, Inc.
uniQure NV
Humacyte, Inc.
bluebird bio, Inc.
MeiraGTx Holdings Plc
23andMe Holding Co.
Terns Pharmaceuticals, Inc.
Aura Biosciences, Inc.
Zura Bio Ltd.
Renovaro, Inc.

Why is Nuvation Bio, Inc. ?

1
The company has declared Negative results for the last 4 consecutive quarters
  • INTEREST(HY) At USD 0.47 MM has Grown at 259.85%
  • OPERATING CASH FLOW(Y) Lowest at USD -168.19 MM
  • OPERATING PROFIT(Q) Lowest at USD -63.23 MM
2
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 208.58%, its profits have fallen by -167.3%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Nuvation Bio, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Nuvation Bio, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Nuvation Bio, Inc.
192.39%
1.92
96.62%
S&P 500
25.41%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
129.67%
EBIT Growth (5y)
-272.67%
EBIT to Interest (avg)
-104.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.08
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
75.69%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.83
EV to EBIT
-5.44
EV to EBITDA
-5.48
EV to Capital Employed
-87.23
EV to Sales
18.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-66.67%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

34What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 9.1 times

NET SALES(Q)

Highest at USD 83.23 MM

OPERATING PROFIT MARGIN(Q)

Highest at 5.31 %

RAW MATERIAL COST(Y)

Fallen by -333.06% (YoY

OPERATING PROFIT(Q)

Highest at USD 4.42 MM

PRE-TAX PROFIT(Q)

Highest at USD 2.53 MM

NET PROFIT(Q)

Highest at USD 2.53 MM

EPS(Q)

Highest at USD 0.01

-11What is not working for the Company
INTEREST(HY)

At USD 13.38 MM has Grown at 9,257.34%

DEBT-EQUITY RATIO (HY)

Highest at -99.12 %

Here's what is working for Nuvation Bio, Inc.

Net Sales
At USD 83.23 MM has Grown at 2,598.7%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely positive

Net Sales (USD MM)

Net Sales
Highest at USD 83.23 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Profit Margin
Highest at 5.31 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
At USD 2.53 MM has Grown at 104.82%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 2.53 MM has Grown at 104.82%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Debtors Turnover Ratio
Highest at 9.1 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Profit
Highest at USD 4.42 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD 2.53 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 2.53 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.01
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -333.06% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nuvation Bio, Inc.

Interest
At USD 13.38 MM has Grown at 9,257.34%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio
Highest at -99.12 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Non Operating Income
Highest at USD 0.99 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income